Ownership history in UBS Group AG · 32 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in ROYALTY PHARMA PLC (RPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 2,005,831 | +1,973,031 | +6015.3% | 0.01% | $77.5M | $38.44 |
| 2025 Q3 | REDUCED | 32,800 | -27,200 | -45.3% | 0.00% | $1.2M | $34.90 |
| 2025 Q3 | REDUCED | 60,000 | -1,481,598 | -96.1% | 0.00% | $2.1M | $34.90 |
| 2025 Q3 | REDUCED | 1,541,598 | -665,167 | -30.1% | 0.01% | $54.4M | $34.90 |
| 2025 Q2 | ADDED | 2,206,765 | +2,173,965 | +6627.9% | 0.01% | $79.5M | $35.43 |
| 2025 Q2 | REDUCED | 32,800 | -27,200 | -45.3% | 0.00% | $1.2M | $35.43 |
| 2025 Q2 | ADDED | 60,000 | +27,200 | +82.9% | 0.00% | $2.2M | $35.43 |
| 2025 Q1 | REDUCED | 32,800 | -1,319,676 | -97.6% | 0.00% | $1.0M | $30.41 |
| 2025 Q1 | ADDED | 1,352,476 | +1,292,476 | +2154.1% | 0.01% | $42.1M | $30.41 |
| 2025 Q1 | ADDED | 60,000 | +10,000 | +20.0% | 0.00% | $1.9M | $30.41 |
As of 2025 Q4 — sorted by position size